Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$4,755,399
+$300,820 QoQ
Shares Held
37,007
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.96%
of 13F equity value
Holder Rank
#1,072
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROWLANDMILLER & PARTNERS.ADV holds $61,867,127 across 7 Drug Manufacturers - General names. MRK ranks #5 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,075 | $18,081,408 | |
| 2 | JNJ |
Johnson & Johnson
|
64,152 | $16,292,683 | |
| 3 | ABBV |
AbbVie Inc.
|
43,246 | $10,882,423 | |
| 4 | AMGN |
Amgen Inc
|
14,748 | $5,340,545 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
37,007 | $4,755,399 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
36,350 | $4,592,459 | |
| 7 | PFE |
Pfizer Inc
|
79,826 | $1,922,210 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,755,399 | 37,007 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,454,579 | 37,032 | Shares | Sole | 2026-04-01 | |
| 2025-12-31 | $4,141,875 | 39,349 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,385,148 | 40,333 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $3,237,485 | 40,898 | Shares | Sole | 2025-07-01 | |
| 2025-03-31 | $3,653,052 | 40,698 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $4,232,675 | 42,548 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $4,945,310 | 43,548 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $5,382,576 | 43,478 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,992,245 | 45,413 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $4,941,113 | 45,323 | Shares | Sole | 2024-01-03 | |
| 2023-09-30 | $4,722,110 | 45,868 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $5,308,170 | 46,002 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $4,910,217 | 46,153 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $5,147,858 | 46,398 | Shares | Sole | 2023-01-04 | |
| 2022-09-30 | $3,995,795 | 46,398 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $4,234,208 | 46,443 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,810,648 | 46,443 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $3,561,997 | 46,477 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,488,634 | 46,447 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,664,289 | 47,117 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $3,628,011 | 47,062 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,767,215 | 46,054 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $3,852,780 | 46,447 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $3,591,748 | 46,447 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $3,573,630 | 46,447 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||